Intellia Therapeutics, Inc.·4

Jan 6, 5:29 PM ET

Hicks Derek 4

4 · Intellia Therapeutics, Inc. · Filed Jan 6, 2023

Insider Transaction Report

Form 4
Period: 2023-01-04
Hicks Derek
EVP, Chief Business Officer
Transactions
  • Sale

    Common Stock

    2023-01-04$37.21/sh1,812$67,42517,306 total
Footnotes (1)
  • [F1]Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 3, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION